# Reperfusion Completion Via Local Arterial Infusion of Tenecteplase After Incomplete Mechanical Thrombectomy

> **NCT07471282** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Chuansheng Zhao** · enrollment: 344 (estimated)

## Conditions studied

- Stroke

## Interventions

- **DRUG:** Tenecteplase (0.0938mg/kg)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07471282
- **Lead sponsor:** Chuansheng Zhao
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2028-12-31
- **Final completion:** 2029-03-31
- **Target enrollment:** 344 (ESTIMATED)
- **Last updated:** 2026-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07471282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07471282, "Reperfusion Completion Via Local Arterial Infusion of Tenecteplase After Incomplete Mechanical Thrombectomy". Retrieved via AI Analytics 2026-07-24 from https://api.ai-analytics.org/clinical/NCT07471282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*